share_log

复旦张江(01349.HK)拟10月25日举行董事会会议批准第三季度业绩

shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349.HK) plans to hold a board of directors meeting on October 25th to approve the third quarter performance.

Gelonghui Finance ·  Oct 14 05:13

Glory Union October 14th | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that a board of directors meeting will be held on October 25, 2024 (Friday) to review and approve (including) the unaudited performance of the company and its subsidiaries for the third quarter ending on October 14, 2024 and its release.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment